Spravato vs. Seroquel: Ketamine Wins Big in Head-to-Head Depression Battle скачать в хорошем качестве

Spravato vs. Seroquel: Ketamine Wins Big in Head-to-Head Depression Battle

In this video, Dr. Tracey Marks provides an update on ketamine's use in treating depression, focusing on its mechanism as an NMDA receptor antagonist and role in neuroplasticity. She discusses the FDA approval of Spravato, a ketamine nasal spray, and compares its effectiveness with quetiapine. The video also explores the emerging role of ketamine injections and the continued success of intravenous ketamine, highlighting their potential in mental health treatment, especially for treatment-resistant depression. SHOP THE MENTAL WELLNESS STORE https://mentalwellnessspace.store/ JOIN MY MENTAL WELLNESS COMMUNITY. Take your mental health education to the next level. https://MentalWellnessSpace.com GET MY ANXIETY BOOK https://amzn.to/4aLrv8m MY AMAZING VIDEO EDITOR https://www.5filmsmedia.com/contact (this is not an affiliate link but a resource. I've had long relationship with Ruslan and his company, so use my name and he will hook you up! 😊 You can tell him I said that) WANT TO START IN THERAPY? Here’s a convenient and affordable option with my sponsor BetterHelp https://Betterhelp.com/drmarks For a monthly fee, you get a REAL licensed therapist with whom you can meet weekly by phone, video or chat. You can also send daily messages. For a full review of the service, watch this video    • BetterHelp Review: An In Depth Look   If you use this link you will get a 10% discount on your first month. https://betterhelp.com/drmarks This is an option I've researched. I get a referral commission if you sign up. References Reif A, Bitter I, Buyze J, et al. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. N Engl J Med. 2023;389(14):1298-1309. doi:10.1056/NEJMoa2304145 Loo C, Glozier N, Barton D, et al. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. The British Journal of Psychiatry. 2023;223(6):533-541. doi:10.1192/bjp.2023.79 Want to know more about mental health and self-improvement? On this channel I discuss topics such as bipolar disorder, major depression, anxiety disorders, attention deficit disorder (ADHD), relationships and personal development/self-improvement. I upload weekly. If you don’t want to miss a video, click here to subscribe. https://goo.gl/DFfT33 Disclaimer: All of the information on this channel is for educational purposes and not intended to be specific/personal medical advice from me to you. Watching the videos or getting answers to comments/question, does not establish a doctor-patient relationship. If you have your own doctor, perhaps these videos can help prepare you for your discussion with your doctor.